NCT00637143View on ClinicalTrials.gov

Tacrolimus as Secondary Intervention vs. Continuation of Cyclosporine in Renal Transplant Patients With Chronic Renal Allograft Failure (CRAF)

PHASE4CompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

April 30, 1999

Primary Completion Date

February 28, 2006

Study Completion Date

February 28, 2006

Conditions
Renal TransplantationChronic Renal Allograft Failure
Interventions
DRUG

Tacrolimus

Oral

DRUG

Cyclosporine

Oral

Trial Locations (13)

T2N 2T9

Calgary

T6G 2B7

Edmonton

V5Z 1M9

Vancouver

R3A 1R9

Winnipeg

A1B 3V6

St. John's

B3H 1V8

Halifax

L8N 4A6

Hamilton

N6A 5A5

London

M5C 2T2

Toronto

M5G 2N2

Toronto

H1T 2M4

Montreal

H3A 1A1

Montreal

S7M 0Z9

Saskatoon

Sponsors
All Listed Sponsors
collaborator

Astellas Pharma Canada, Inc.

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY